These results reveal that, despite a relatively similar abundance of CX3CR1+CD206+ macrophages that were previously associated with progressively growing tumors,22,24 neoAg SLP vax induces tumor regression equivalent to ICT when initiated at day 7 post-transplant. This evidence concerns the gene MRC1 and neoplasm.